Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging
- PMID: 35178237
- PMCID: PMC8843974
- DOI: 10.1155/2022/8446294
Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging
Retraction in
-
Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.J Healthc Eng. 2023 Jul 12;2023:9862864. doi: 10.1155/2023/9862864. eCollection 2023. J Healthc Eng. 2023. PMID: 37476775 Free PMC article.
Abstract
We have proposed an effective mechanism to corroborate the efficacy of microwave ablation (MA) in the treatment of stage I renal clear cell carcinoma in this paper. For this purpose, a total of 96 patients with stage I renal clear cell carcinoma presented in our hospital from May 2018 to January 2021 were randomly divided into CT group (n = 48) and MRI group (n = 48). Patients in both groups were treated with microwave ablation after pathological diagnosis. Patients in the CT group received enhanced CT examination to monitor the therapeutic effect; in contrast, patients in the MRI group received MRI examination to monitor their therapeutic effect. The focus areas before and after tumor microwave ablation were compared between the two groups. The patients were followed up to 1 year after the operation, and the microwave ablation inactivation rates of the two groups were compared according to the postoperative follow-up results. There was no significant difference between CT and MRI in the levels of long and short diameter before and after microwave ablation of renal clear cell carcinoma (P > 0.05). In the CT group, CT examination was performed within 24 hours after microwave ablation treatment, and 44 of 48 ablation lesions showed complete ablation. The remaining 4 lesions showed nodular heterogeneous enhancement in the arterial phase, indicating that the tumor remained. Microwave ablation was performed on the residual lesions during the operation, and then enhanced CT was performed again to show that the lesions were ablated completely. In the MRI group, MRI examination was performed within 24 hours after microwave ablation treatment, and 45 of 48 ablation lesions showed complete ablation. The remaining 3 lesions showed nodular heterogeneous enhancement in the arterial phase, indicating that the tumor remained. Microwave ablation was performed on the residual lesions during the operation, and MRI examination showed that the lesions were ablated completely. The patients were followed up to 1 year after the operation, and the microwave ablation inactivation rate of the two groups was compared according to the postoperative follow-up results as the gold standard. The inactivation rate of microwave ablation in the CT group was 89.58 (43/48). The inactivation rate of microwave ablation in the MRI group was 100.00% (48/48). The inactivation rate of microwave ablation in the MRI group was higher than that in the CT group (χ 2 = 5.275, P = 0.021).
Copyright © 2022 Jiang Zhu et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.Abdom Radiol (NY). 2020 Sep;45(9):2810-2824. doi: 10.1007/s00261-020-02662-9. Epub 2020 Jul 26. Abdom Radiol (NY). 2020. PMID: 32715335
-
Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma.Cardiovasc Intervent Radiol. 2021 Feb;44(2):281-288. doi: 10.1007/s00270-020-02674-4. Epub 2020 Oct 19. Cardiovasc Intervent Radiol. 2021. PMID: 33078234
-
Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.Int J Hyperthermia. 2021;38(1):691-695. doi: 10.1080/02656736.2021.1915503. Int J Hyperthermia. 2021. PMID: 33899668
-
Percutaneous microwave ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy.Int J Hyperthermia. 2018 Nov;34(7):1077-1081. doi: 10.1080/02656736.2017.1408147. Epub 2017 Dec 4. Int J Hyperthermia. 2018. PMID: 29202667 Review.
-
Imaging analysis of 13 rare cases of renal collecting (Bellini) duct carcinoma in northern China: a case series and literature review.BMC Med Imaging. 2021 Mar 6;21(1):42. doi: 10.1186/s12880-021-00574-8. BMC Med Imaging. 2021. PMID: 33676411 Free PMC article. Review.
Cited by
-
Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.J Healthc Eng. 2023 Jul 12;2023:9862864. doi: 10.1155/2023/9862864. eCollection 2023. J Healthc Eng. 2023. PMID: 37476775 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical